A recent report suggested that a typical pharmaceutical manufacturing factory will spend approximately $40M on quality control every year. 1 Meanwhile, another report highlighted that 79% of the 483 ...

The U.S. FDA wants pharmaceutical companies to move from a focus on compliance to with GMPs to a focus on product and process quality. How will this affect the methods and tools for process ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Frost & Sullivan has released a white paper titled, "How Leading Global Pharma Embraces AI to Automate Regulatory and Medical ...

Analytical quality control refers to all those processes and procedures designed to ensure that the results of laboratory analysis are consistent, comparable, accurate and within specified limits.

State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture has the following research output in the current window (1 October 2024 - 30 ...

Pharmaceutical manufacturing requires defining quality target product profiles and critical quality attributes (CQAs) to ensure desired product quality. Process development identifies critical process ...

When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...

Biopharma quality control is being revolutionized by advanced analytics and digital transformation through a synergy that boosts quality and scalability. *Full transcript available below. Digital ...

In November 2016, Continuus Pharmaceuticals was awarded a $4.4 million contract by the U.S. Food and Drug Administration (FDA). The partnership revolves around a pilot project that will result in a ...

The global Pharmaceutical Isolator market was valued at USD 432 Million in the year 2024 and is projected to reach a revised size of USD 509 Million by 2031, growing at a CAGR of 2.4% during the ...